Advances in Circulating Tumor Cells Research

Circulating tumor cells (CTCs) are cells that have shed into the vasculature or lymphatics from a primary tumor and are carried around the body in the circulation. CTCs thus constitute seeds for the subsequent growth of additional tumors (metastases) in vital distant organs, triggering a mechanism that is responsible for the vast majority of cancer-related deaths. Modern cancer research has demonstrated that CTCs derive from clones in the primary tumor. The significant efforts put into understanding the CTCs biological properties have demonstrated the critical role circulating tumor cells play in the metastatic spread of carcinoma. Furthermore, highly sensitive, single-cell analysis demonstrated a high level of heterogeneity seen at the single cell level for both protein expression and protein localization and the CTCs reflected both the primary biopsy and the changes seen in the metastatic sites. Tissue biopsies are poor diagnostic procedures: they are invasive, cannot be used repeatedly, and are ineffective in understanding metastatic risk, disease progression, and treatment effectiveness. CTCs thus could be considered a “liquid biopsy” which reveals metastasis in action, providing live information about the patient’s disease status.


In the present book, fifteen typical literatures about circulating tumor cells published on international authoritative journals were selected to introduce the worldwide newest progress, which contains reviews or original researches on medical science, oncology, anatomical pathology, biopsy, ect. We hope this book can demonstrate advances in circulating tumor cells as well as give references to the researchers, students and other related people.

Components of the Book:
  • Chapter 1
    Matrix Metalloproteinase 1 and Circulating Tumor Cells in Early Breast Cancer
  • Chapter 2
    Application of Circulating Tumor Cells Scope Technique on Circulating Tumor Cell Research
  • Chapter 3
    Evaluation of Proliferation and Apoptosis Markers in Circulating Tumor Cells of Women with Early Breast Cancer Who Are Candidates for Tumor Dormancy
  • Chapter 4
    A Cell Transportation Solution That Preserves Live Circulating Tumor Cells in Patient Blood Samples
  • Chapter 5
    Single Cell Mutational Analysis of PIK3CA in Circulating Tumor Cells and Metastases in Breast Cancer Reveals Heterogeneity, Discordance, and Mutation Persistence in Cultured Disseminated Tumor Cells from Bone Marrow
  • Chapter 6
    Circulating Tumor Cells (CTC) and KRAS Mutant Circulating Free DNA (CfDNA) Detection in Peripheral Blood as Biomarkers in Patients Diagnosed with Exocrine Pancreatic Cancer
  • Chapter 7
    Cytokeratin 20 Positive Circulating Tumor Cells Are a Marker for Response after Neoadjuvant Chemoradiation but Not for Prognosis in Patients with Rectal Cancer
  • Chapter 8
    Nanoroughened Adhesion-Based Capture of Circulating Tumor Cells with Heterogeneous Expression and Metastatic Characteristics
  • Chapter 9
    Meta-Analysis Shows That Circulating Tumor Cells Including Circulating MicroRNAs Are Useful to Predict the Survival of Patients with Gastric Cancer
  • Chapter 10
    Prognostic Value of Circulating Tumor Cells and Disseminated Tumor Cells in Patients with Ovarian Cancer: A Systematic Review and Meta-Analysis
  • Chapter 11
    Efficiency of Whole Genome Amplification of Single Circulating Tumor Cells Enriched By CellSearch and Sorted by FACS
  • Chapter 12
    Does Primary Neoadjuvant Systemic Therapy Eradicate Minimal Residual Disease? Analysis of Disseminated and Circulating Tumor Cells before and after Therapy
  • Chapter 13
    Comparison of the HER2, Estrogen and Progesterone Receptor Expression Profile of Primary Tumor, Metastases and Circulating Tumor Cells in Metastatic Breast Cancer Patients
  • Chapter 14
    A Novel Oxygen Carrier “YQ23” Suppresses the Liver Tumor Metastasis by Decreasing Circulating Endothelial Progenitor Cells and Regulatory T Cells
  • Chapter 15
    A Rare Case of Extremely High Counts of Circulating Tumor Cells Detected in a Patient with an Oral Squamous Cell Carcinoma
Readership: Students, academics, teachers and other people attending or interested in Circulating Tumor Cells Research.
Dawei Yang, Department of Pulmonary Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.

Sofia Agelaki, Laboratory of Tumor Cell Biology, School of Medicine, University of Crete, Voutes University Campus, Heraklion, Crete, Greece.

Glenn Deng, Division of Surgical Oncology, Stanford University School of Medicine, Stanford, CA 94305, USA.

Julie Earl, Medical Oncology Department, Ramón y Cajal University Hospital, Carretera de Colmenar Viejo, Madrid, Spain.

Sebastian Hinz, Department of General and Thoracic Surgery, University Hospital Schleswig-Holstein, Campus Kiel, Arnold-Heller Str. 7, 24105 Kiel, Germany.

Marcelo De Carvalho Bittencourt, Laboratory of Immunology, Nancytomique platform, CHRU of Nancy, rue du Morvan, Vandoeuvre-lès-Nancy, France.

and more...
Copyright © 2006-2024 Scientific Research Publishing Inc. All Rights Reserved.
Top